SLQT Investors Have Opportunity to Lead SelectQuote, Inc. Securities Lawsuit

Core Viewpoint - A class action lawsuit has been filed against SelectQuote, Inc. for misleading statements and actions regarding its business practices related to Medicare beneficiaries, potentially affecting investors who purchased securities between September 9, 2020, and May 1, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit alleges that SelectQuote directed Medicare beneficiaries to insurers that compensated the company best, rather than providing unbiased comparisons [5]. - It is claimed that SelectQuote received illegal kickbacks to steer beneficiaries towards certain insurers, which may have violated laws and regulations [5]. - The lawsuit asserts that the misleading statements made by SelectQuote regarding its business operations led to investor damages when the truth was revealed [5]. Group 2: Participation Information - Investors who purchased SelectQuote securities during the class period may be entitled to compensation without upfront fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. - A lead plaintiff must file a motion by October 10, 2025, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its success in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4].